The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 16, 2019

Filed:

Oct. 20, 2015
Applicant:

Genomic Health, Inc., Redwood City, CA (US);

Inventors:

Steven Shak, Hillsborough, CA (US);

Frederick L. Baehner, San Francisco, CA (US);

Tara Maddala, Sunnyvale, CA (US);

Mark Lee, Los Altos Hills, CA (US);

Robert J. Pelham, Belmont, CA (US);

Wayne Cowens;

Diana Cherbavaz, San Francisco, CA (US);

Michael C. Kiefer, Walnut Creek, CA (US);

Michael Crager, Menlo Park, CA (US);

Audrey Goddard, San Francisco, CA (US);

Joffre B. Baker, Montara, CA (US);

Assignee:

Genomic Health, Inc., Redwood City, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G06F 19/00 (2018.01); C12Q 1/6886 (2018.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); G06F 19/00 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/158 (2013.01); C12Q 2600/178 (2013.01);
Abstract

The present disclosure includes assays that involve measurement of expression levels of prognostic biomarkers, or co-expressed biomarkers, from a biological sample obtained from a prostate cancer patient, and analysis of the measured expression levels to provide information concerning the likely prognosis for the patient, and likelihood that the patient will have a recurrence of prostate cancer, or to classify the tumor by likelihood of clinical outcome or TMPRSS2 fusion status.


Find Patent Forward Citations

Loading…